Baird analyst Peter Arment downgrades Maxar Technologies (NYSE:MAXR) from Outperform to Neutral and raises the price target from $45 to $53.
Baird Downgrades Maxar Technologies to Neutral, Raises Price Target to $53
Baird analyst Peter Arment downgrades Maxar Technologies (NYSE:MAXR) from Outperform to Neutral and raises the price target from $45 to $53.
Related Posts
Ford, Chrysler Dominate 2023’s Recall Frenzy But Tesla Remains Unseen Among Top 10
December 27, 3:31 AM
According to data from NHTSA, Ford reported 55 recalls, potentially impacting around 5.9 million vehicles.
Why Cardio Diagnostics Holdings Stock Is Racing Higher
January 2, 12:41 PM
Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) shares are rocketing higher Tuesday after the company announced that the American Medical Association (AMA) has assigned a dedicated Current Procedural Terminology (CPT) Proprietary Laboratory Analysis (PLA), for the company's
Baird Maintains Neutral on Fleetcor Technologies, Lowers Price Target to $220
September 26, 1:59 PM
Baird analyst David Koning maintains Fleetcor Technologies (NYSE:FLT) with a Neutral and lowers the price target from $250 to $220.